543500 — Evoq Remedies Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹88.64m
- IN₹85.57m
- IN₹117.57m
- 40
- 90
- 24
- 51
Annual cashflow statement for Evoq Remedies, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | R2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 7.15 | 14.6 | 22.8 | 6.11 | 1.28 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 0.002 | 0.046 | 0.013 | — | — |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -6.85 | -279 | -66.4 | 47 | -148 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 0.311 | -264 | -43.5 | 53.2 | -146 |
| Capital Expenditures | 0 | 0 | -0.131 | -0.12 | -2.58 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0 | 0 | 0 | — | — |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | 0 | 0 | -0.131 | -0.12 | -2.58 |
| Financing Cash Flow Items | 0 | 0 | 0 | 0 | 0 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0 | 295 | 14.2 | -53.4 | 150 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.311 | 30.6 | -29.4 | -0.302 | 0.907 |